OCUGEN, INC. Operating Expenses
OCUGEN, INC. (OCGN) reported Operating Expenses of $17.93 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- OCUGEN, INC. operating expenses for the quarter ending 2026-06-30 was $17.93M, a 18.22% increase year-over-year.
- OCUGEN, INC. operating expenses for the quarter ending 2026-03-31 was $19.37M, a 21.21% increase year-over-year.
- OCUGEN, INC. operating expenses for the quarter ending 2025-12-31 was $16.80M, a 15.05% increase year-over-year.
- OCUGEN, INC. operating expenses for the quarter ending 2025-09-30 was $19.38M, a 34.67% increase year-over-year.
- OCUGEN, INC. operating expenses for fiscal 2025 was $67.33M, a 14.48% increase from fiscal 2024.
- OCUGEN, INC. operating expenses for fiscal 2024 was $58.81M, a 17.82% decline from fiscal 2023.
- OCUGEN, INC. operating expenses for fiscal 2023 was $71.57M, a 21.84% decline from fiscal 2022.
- OCUGEN, INC. operating expenses for fiscal 2022 was $91.56M, a 57.78% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $17.93M 10-Q · filed 2026-08-06 | $37.30M 10-Q · filed 2026-08-06 | $54.11M derived: sum of 3 quarters · filed 2026-08-06 | $73.48M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $19.37M 10-Q · filed 2026-05-08 | $36.17M derived: sum of 2 quarters · filed 2026-05-08 | $55.55M derived: sum of 3 quarters · filed 2026-05-08 | $70.72M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $16.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $36.18M derived: sum of 2 quarters · filed 2026-03-04 | $51.35M derived: sum of 3 quarters · filed 2026-08-06 | $67.33M 10-K · filed 2026-03-04 | ||||
| 2025-09-30 | $19.38M 10-Q · filed 2025-11-05 | $34.55M derived: sum of 2 quarters · filed 2026-08-06 | $50.53M 10-Q · filed 2025-11-05 | $65.13M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $15.17M 10-Q · filed 2026-08-06 | $31.15M 10-Q · filed 2026-08-06 | $45.75M derived: sum of 3 quarters · filed 2026-08-06 | $60.14M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $15.98M 10-Q · filed 2026-05-08 | $30.59M derived: sum of 2 quarters · filed 2026-05-08 | $44.97M derived: sum of 3 quarters · filed 2026-05-08 | $61.56M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | $14.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $28.99M derived: sum of 2 quarters · filed 2026-03-04 | $45.58M derived: sum of 3 quarters · filed 2026-03-04 | $58.81M 10-K · filed 2026-03-04 | ||||
| 2024-09-30 | $14.39M 10-Q · filed 2025-11-05 | $30.98M derived: sum of 2 quarters · filed 2025-11-05 | $44.21M 10-Q · filed 2025-11-05 | $57.14M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | $16.59M 10-Q · filed 2025-08-04 | $29.82M 10-Q · filed 2025-08-04 | $42.75M derived: sum of 3 quarters · filed 2025-08-04 | $58.88M derived: sum of 4 quarters · filed 2025-08-04 | ||||
| 2024-03-31 | $13.23M 10-Q · filed 2025-05-09 | $26.16M derived: sum of 2 quarters · filed 2025-05-09 | $42.29M derived: sum of 3 quarters · filed 2025-05-09 | $66.32M derived: sum of 4 quarters · filed 2025-05-09 | ||||
| 2023-12-31 | $12.93M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $29.06M derived: sum of 2 quarters · filed 2025-03-05 | $53.09M derived: sum of 3 quarters · filed 2025-03-05 | $71.57M 10-K · filed 2025-03-05 | ||||
| 2023-09-30 | $16.13M 10-Q · filed 2024-11-14 | $15.42M 10-Q · filed 2023-11-09 | $40.16M derived: sum of 2 quarters · filed 2024-11-14 | $58.63M 10-Q · filed 2024-11-14 | $56.91M 10-Q · filed 2023-11-09 | $82.87M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $24.02M 10-Q · filed 2024-08-08 | $23.73M 10-Q · filed 2023-08-21 | $42.50M 10-Q · filed 2024-08-08 | $41.48M 10-Q · filed 2023-08-21 | $66.74M derived: sum of 3 quarters · filed 2024-08-08 | $92.31M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $18.48M 10-Q · filed 2024-05-14 | $17.75M 10-Q · filed 2023-05-05 | $42.71M derived: sum of 2 quarters · filed 2024-05-14 | $68.29M derived: sum of 3 quarters · filed 2024-05-14 | $90.51M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $24.23M derived: 10-K 12 month − 10-K 9 month · filed 2024-04-16 | $49.81M derived: sum of 2 quarters · filed 2024-04-16 | $72.03M derived: sum of 3 quarters · filed 2024-04-16 | $91.56M 10-K · filed 2024-04-16 | $84.87M 10-K · filed 2023-02-28 | |||
| 2022-09-30 | $25.58M 10-K · filed 2024-04-16 | $23.12M 10-Q · filed 2022-11-08 | $47.80M derived: sum of 2 quarters · filed 2024-04-16 | $67.33M 10-K · filed 2024-04-16 | $60.72M 10-Q · filed 2022-11-08 | $81.90M derived: sum of 4 quarters · filed 2024-04-16 | ||
| 2022-06-30 | $22.22M 10-K · filed 2024-04-16 | $19.57M 10-Q · filed 2022-08-05 | $41.75M 10-K · filed 2024-04-16 | $37.60M 10-Q · filed 2022-08-05 | $56.32M derived: sum of 3 quarters · filed 2024-04-16 | $67.11M derived: sum of 4 quarters · filed 2024-04-16 | ||
| 2022-03-31 | $19.53M 10-K · filed 2024-04-16 | $18.03M 10-Q · filed 2022-05-06 | $34.10M derived: sum of 2 quarters · filed 2024-04-16 | $44.89M derived: sum of 3 quarters · filed 2024-04-16 | $70.50M derived: sum of 4 quarters · filed 2024-04-16 | |||
| 2021-12-31 | $14.57M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $25.36M derived: sum of 2 quarters · filed 2023-02-28 | $50.97M derived: sum of 3 quarters · filed 2023-02-28 | $58.03M 10-K · filed 2023-02-28 | ||||
| 2021-09-30 | $10.79M 10-Q · filed 2022-11-08 | $36.40M derived: sum of 2 quarters · filed 2022-11-08 | $43.46M 10-Q · filed 2022-11-08 | $47.26M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $25.61M 10-Q · filed 2022-08-05 | $32.67M 10-Q · filed 2022-08-05 | $36.48M derived: sum of 3 quarters · filed 2022-08-05 | $46.66M derived: sum of 4 quarters · filed 2022-08-05 | ||||
| 2021-03-31 | $7.06M 10-Q · filed 2022-05-06 | $10.87M derived: sum of 2 quarters · filed 2022-05-06 | $21.05M derived: sum of 3 quarters · filed 2022-05-06 | $24.46M derived: sum of 4 quarters · filed 2022-05-06 | ||||
| 2020-12-31 | $3.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $13.99M derived: sum of 2 quarters · filed 2022-02-28 | $17.40M derived: sum of 3 quarters · filed 2022-02-28 | $21.33M 10-K · filed 2022-02-28 | $21.33M 10-K · filed 2021-03-19 | |||
| 2020-09-30 | $10.18M 10-Q · filed 2021-11-09 | $10.18M 10-Q · filed 2020-11-06 | $13.59M derived: sum of 2 quarters · filed 2021-11-09 | $17.52M 10-Q · filed 2021-11-09 | $17.52M 10-Q · filed 2020-11-06 | $21.80M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-06-30 | $3.41M 10-Q · filed 2021-08-06 | $3.41M 10-Q · filed 2020-08-14 | $7.34M 10-Q · filed 2021-08-06 | $7.34M 10-Q · filed 2020-08-14 | $11.62M derived: sum of 3 quarters · filed 2022-02-28 | $14.33M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-03-31 | $3.93M 10-Q · filed 2021-05-07 | $3.93M 10-Q · filed 2020-05-08 | $8.21M derived: sum of 2 quarters · filed 2022-02-28 | $10.92M derived: sum of 3 quarters · filed 2022-02-28 | $13.25M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $4.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $6.99M derived: sum of 2 quarters · filed 2022-02-28 | $9.32M derived: sum of 3 quarters · filed 2022-02-28 | $14.16M 10-K · filed 2022-02-28 | $14.16M 10-K · filed 2020-03-27 | |||
| 2019-09-30 | $2.71M 10-Q · filed 2020-11-06 | $5.04M derived: sum of 2 quarters · filed 2020-11-06 | $9.88M 10-Q · filed 2020-11-06 | $15.57M derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | $2.33M 10-Q · filed 2020-08-14 | $3.06M 10-Q · filed 2019-08-09 | $7.17M 10-Q · filed 2020-08-14 | $11.11M 10-Q · filed 2019-08-09 | $12.86M derived: sum of 3 quarters · filed 2020-08-14 | $15.26M derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2019-03-31 | $4.84M 10-Q · filed 2020-05-08 | $8.05M 10-Q · filed 2019-05-15 | $10.53M derived: sum of 2 quarters · filed 2020-05-08 | $12.93M derived: sum of 3 quarters · filed 2020-05-08 | $16.99M derived: sum of 4 quarters · filed 2020-05-08 | |||
| 2018-12-31 | $5.69M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $8.09M derived: sum of 2 quarters · filed 2020-03-27 | $12.15M derived: sum of 3 quarters · filed 2020-03-27 | $16.14M 10-K · filed 2020-03-27 | $30.11M 10-K · filed 2019-03-22 | |||
| 2018-09-30 | $2.40M 10-Q · filed 2019-11-12 | $6.99M 10-Q · filed 2018-11-08 | $6.46M derived: sum of 2 quarters · filed 2019-11-12 | $10.45M 10-Q · filed 2019-11-12 | $20.37M 10-Q · filed 2018-11-08 | $18.58M derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | $4.05M 8-K/A · filed 2019-10-07 | $7.28M 10-Q · filed 2018-08-09 | $8.05M 8-K/A · filed 2019-10-07 | $13.38M 10-Q · filed 2018-08-09 | $16.18M derived: sum of 3 quarters · filed 2019-10-07 | $21.89M derived: sum of 4 quarters · filed 2019-10-07 | ||
| 2018-03-31 | $6.09M 10-Q · filed 2019-05-15 | $12.13M derived: sum of 2 quarters · filed 2019-05-15 | $17.84M derived: sum of 3 quarters · filed 2019-05-15 | $24.21M derived: sum of 4 quarters · filed 2019-05-15 | ||||
| 2017-12-31 | $6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $11.75M derived: sum of 2 quarters · filed 2019-03-22 | $18.12M derived: sum of 3 quarters · filed 2019-03-22 | $24.95M 10-K · filed 2019-03-22 | ||||
| 2017-09-30 | $5.71M 10-Q · filed 2018-11-08 | $12.09M derived: sum of 2 quarters · filed 2018-11-08 | $18.92M 10-Q · filed 2018-11-08 | $26.82M derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | $6.37M 10-Q · filed 2018-08-09 | $13.20M 10-Q · filed 2018-08-09 | $21.11M derived: sum of 3 quarters · filed 2018-08-09 | $27.76M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $6.83M 10-Q · filed 2018-05-10 | $14.74M derived: sum of 2 quarters · filed 2018-05-10 | $21.38M derived: sum of 3 quarters · filed 2018-05-10 | $29.34M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | $7.91M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $14.55M derived: sum of 2 quarters · filed 2018-03-15 | $22.51M derived: sum of 3 quarters · filed 2018-03-15 | $30.31M 10-K · filed 2018-03-15 | ||||
| 2016-09-30 | $6.65M 10-Q · filed 2017-11-09 | $14.60M derived: sum of 2 quarters · filed 2017-11-09 | $22.40M 10-Q · filed 2017-11-09 | $30.71M derived: sum of 4 quarters · filed 2017-11-09 | ||||
| 2016-06-30 | $7.96M 10-Q · filed 2017-08-10 | $15.75M 10-Q · filed 2017-08-10 | $24.07M derived: sum of 3 quarters · filed 2017-08-10 | $32.11M derived: sum of 4 quarters · filed 2017-08-10 | ||||
| 2016-03-31 | $7.80M 10-Q · filed 2017-05-11 | $16.11M derived: sum of 2 quarters · filed 2017-05-11 | $24.15M derived: sum of 3 quarters · filed 2017-05-11 | $31.74M derived: sum of 4 quarters · filed 2017-05-11 | ||||
| 2015-12-31 | $8.31M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $16.35M derived: sum of 2 quarters · filed 2017-03-16 | $23.95M derived: sum of 3 quarters · filed 2017-03-16 | $31.82M 10-K · filed 2017-03-16 | ||||
| 2015-09-30 | $8.04M 10-Q · filed 2016-11-10 | $15.63M derived: sum of 2 quarters · filed 2016-11-10 | $23.50M 10-Q · filed 2016-11-10 | $30.04M derived: sum of 4 quarters · filed 2016-11-10 | ||||
| 2015-06-30 | $7.59M 10-Q · filed 2016-08-11 | $15.47M 10-Q · filed 2016-08-11 | $22.00M derived: sum of 3 quarters · filed 2016-08-11 | $36.95M derived: sum of 4 quarters · filed 2016-08-11 | ||||
| 2015-03-31 | $7.87M 10-Q · filed 2016-05-12 | -$7.87M 10-Q · filed 2015-05-14 | $14.41M derived: sum of 2 quarters · filed 2016-05-12 | $29.35M derived: sum of 3 quarters · filed 2016-05-12 | $35.36M derived: sum of 4 quarters · filed 2016-05-12 | |||
| 2014-12-31 | $6.54M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $21.48M derived: sum of 2 quarters · filed 2016-03-10 | $27.49M derived: sum of 3 quarters · filed 2016-03-10 | $32.66M 10-K · filed 2016-03-10 | ||||
| 2014-09-30 | $14.94M 10-Q · filed 2015-11-12 | $20.95M derived: sum of 2 quarters · filed 2015-11-12 | $26.12M 10-Q · filed 2015-11-12 | |||||
| 2014-06-30 | $6.01M 10-Q · filed 2015-08-12 | $11.18M 10-Q · filed 2015-08-12 | ||||||
| 2014-03-31 | -$5.17M 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |